NEW TECHNOLOGY EXPORT DEAL SECURED BY ALTEOGEN

HIGHLIGHTS

• Alteogen has signed a new technology export contract with a pharmaceutical company.
• ALT-B4 can replace intravenous drugs with subcutaneous drugs.
• ALT-B4 is a human hyaluronidase technology.

South Korean bio company Alteogen has secured a new technology export contract with an unnamed global pharmaceutical company. This contract is for technology export regard....